Low-dosage intravenous immunoglobulin in the management of a patient with acquired von willebrand syndrome associated with monoclonal gammopathy of undetermined significance

Pathophysiology of Haemostasis and Thrombosis

Volumn 32, Issue 1, 2002, Pages 33-39

  Hayashi, T ^a   Yagi, H ^b   Suzuki, H ^a   Nonaka, Y ^a   Nomura, T ^a   Sakurai, Y ^b   Shibata, M ^b   Matsumoto, M ^b   Yamamoto, Y ^b   Fujimura, Y ^b  

^a TOKYO METROPOLITAN POLICE HOSPITAL   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Acquired von Willebrand syndrome; Inhibitor; Low dosage immunoglobulin therapy; Monoclonal gammopathy

Indexed keywords

IMMUNOGLOBULIN;

AGED; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; GAMMOPATHY; HUMAN; LOW DRUG DOSE; MACROPHAGE; MALE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; RECEPTOR BINDING; TOOTH EXTRACTION; TREATMENT OUTCOME; VON WILLEBRAND DISEASE;

ADAM PROTEINS; AGED; DISEASE MANAGEMENT; HEMORRHAGE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; ISOANTIBODIES; MALE; METALLOENDOPEPTIDASES; MONOCLONAL GAMMOPATHIES, BENIGN; TOOTH EXTRACTION; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 10744220383     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057286     Document Type: Article

References (24)

1. Mannucci PM, Lombardi R, Bader R, Horellou MH, Finazzi G, Besana C, Conard J, Samama M: Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies. Blood 1984; 64:614-621.
2. Rinder MR, Richard RE, Rinder HM: Acquired von Willebrand's disease: A concise review. Am J Hematol 1997;54:139-145.
3. Veyradier A, Jenkins CS, Fressinaud E, Meyer D: Acquired von Willebrand syndrome: From pathophysiology to management. Thromb Haemost 2000;84:175-182.
4. Federici AB, Rand JH, Bucciarelli P, Budde U, van Genderen PJJ, Mohri H, Meyer D, Rodeghiero F, Sadler JE: Acquired von Willebrand syndrome: Data from an international registry. On behalf of the subcommittee on von Willebrand factor. Thromb Haemost 2000;84:345-349.
5. Ruggeri ZM, Ware J: von Willebrand factor. FASEB J 1993;7:308-316.
6. Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lämmle B: Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 1997;89:3097-3103.
7. Fujimura Y, Ikeda Y, Miura S, Yoshida E, Shima H, Nishida S, Suzuki M, Titani K, Taniuchi Y, Kawasaki T: Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib. Thromb Haemost 1995;74:743-750.
8. Hardisty RM, MacPherson JC: A one-stage factor VIII (anti-haemophilic globulin) assay and its use on venous and capillary plasma. Thromb Diath Haemorrh 1962;7:215-229.
9. Bartlett A, Dormandy KM, Hawkey CM, Stableforth P, Voller A: Factor-VIII-related antigen: Measurement by enzyme immunoassay. Br Med J 1976;i:994-996.
10. Macfarlane DE, Stibbe J, Kirby EP, Zucker MB, Grant RA, McPherson J: A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh 1975;34: 306-308.
11. Kasper CK, Alendon LM, Counts RB, Edson JR, Fratantoni J, Green D, Hampton JW, Hilgartner MW, Lazerson J, Levine PH, McMillan CW, Pool JG, Shapiro SS, Shulman NR, van Eys J: A more uniform measurement of factor VIII inhibitors. Thromb Diath Haematol 1975; 34:869-872.
12. Kinoshita S, Yoshioka A, Park Y-D, Ishizashi H, Konno M, Funato M, Matsui T, Titani K, Yagi H, Matsumoto M, Fujimura Y: Upshaw-Schulman syndrome revisited: A concept of congenital thrombotic thrombocytopenic purpura. Int J Hematol 2001;74:101-108.
13. Yagi H, Konno M, Kinoshita S, Matsumoto M, Ishizashi H, Matsui T, Titani K, Fujimura Y: Plasma of patients with Upshaw-Schulman syndrome, a congenital deficiency of von Willebrand factor-cleaving protease, enhances the aggregation of normal platelets under high shear stress. Br J Haematol 2001;115:991-997.
14. Ruggeri ZM, Zimmerman TS: The complex multimeric composition of factor VIII/von Willebrand factor. Blood 1981;57:1140-1143.
15. Budde U, Schneppenheim R, Plendl H, Dent J, Ruggeri ZM, Zimmerman TS: Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes. Thromb Haemost 1990;63:312-315.
16. Shibata M, Shima M, Fujimura Y, Takahashi Y, Nakai H, Sakurai Y, Asatani M, Nomura A, Take H, Giddings JC, Yoshioka A: Identification of the binding site for an alloantibody to von Willebrand factor which inhibits binding to glycoprotein Ib within the amino-terminal region flanking the A1 domain. Thromb Haemost 1999;81:793-798.
17. Federici AB, Stabile F, Castaman G, Canciani MT, Mannucci PM: Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: Comparison of three different therapeutic approaches. Blood 1998;92:2707-2711.
18. Mohri H, Motomura S, Kanamori H, Matsuzaki M, Watanabe S, Maruta A, Kodama F, Okubo T: Clinical significance of inhibitors in acquired von Willebrand syndrome. Blood 1998; 91:3623-3629.
19. Macik BG, Gabriel DA, White GC II, High K, Roberts H: The use of high-dose intravenous γ-globulin in acquired von Willebrand syndrome. Arch Pathol Lab Med 1988;112:143-146.
20. Meyer D, Frommel D, Larrieu MJ, Zimmerman TS: Selective absence of large forms of factor VIII/von Willebrand factor in acquired von Willebrand's syndrome. Response to transfusion. Blood 1979;54:600-606.
21. López-Fernández MF, López-Berges C, Martín R, Nieto J, del Rio F, López-Borrasca A, Batlle J: Unique multimeric pattern of von Willebrand factor in a patient with a benign monoclonal gammopathy. Scand J Haematol 1986; 36:302-308.
22. Takahashi H, Nagayama R, Tanabe Y, Satoh K, Hanano M, Mito M, Shibata A: DDAVP in acquired von Willebrand syndrome associated with multiple myeloma. Am J Hematol 1986; 22:421-429.
23. Brody JI, Haidar ME, Rossman RE: A hemorrhagic syndrome in Waldenström's macroglobulinemia secondary to immunoadsorption of factor VIII. Recovery after splenectomy. N Engl J Med 1979;300:408-410.
24. Richard C, Cuadrado MA, Prieto M, Batlle J, López- Fernández MF, Rodriguez-Salazar ML, Bello C, Recio M, Santoro T, Gomez-Casares MT, Zubizarreta A: Acquired von Willebrand disease in multiple myeloma secondary to absorption of von Willebrand factor by plasma cells. Am J Hematol 1990;35:114-117.